logo
The Steering Committee
Alastair Carruthers, MD, FRCP(C)
Site Disclaimer
eHealthcare Leadership Awards 2007 Winner
You need to upgrade your Flash Player
You need to upgrade your Flash Player to view this content.

What's New

• Environmental effects on skin aging, potential adverse events of onabotulinumtoxinA
Our newest slides explore the effects of environmental factors, including skin cancer history and smoking, on skin aging. We also explore a study of the safety and tolerability of onabotulinumtoxinA for facial lines.

• FDA Gives Update on Botulinum Toxin Safety Warnings; Established Names of Drugs Changed
The FDA announced an update to a previous safety alert on four botulinum toxin drug products, noting that all of them now have boxed warnings on their labels and have developed Medication Guides for patients, as directed by the agency in April 2009. More here.

• FDA Requires Boxed Warning for Botulinum Toxin Products
The FDA has notified the manufacturers of licensed botulinum toxin products of the need to strengthen warnings in labeling and add a boxed warning regarding the risk of adverse events when the effects of the toxin spread beyond the site where it was injected. The FDA also urges manufacturers to develop and implement a Risk Evaluation and Mitigation Strategy (REMS) to ensure that product benefits outweigh risk.

• FDA Warning Letter Sent for Bimatoprost Ophthalmic Solution (Latisse™)
The FDA issued a warning letter to Allergan, Inc., manufacture of the eyelash enhancer, bimatoprost ophthalmic solution (Latisse™), for minimizing risks associated with the product's use. More here.

Slides of the Month

 

In The News

Maryland Legislation Introduced To Prohibit Indoor Tanning For Minors
Mar 11, 2010 -- New Maryland legislation to protect youth from melanoma, the deadliest form of skin cancer, is based on significant scientific evidence that indoor tanning before the age of 30 is undeniably linked to increased risk of developing the disease. Senator James N. Robey and Delegate William A...
New Data Presented At American Burn Association's Annual Meeting Support Safety Profile Of RECOTHROM Thrombin, Topical In Pediatric Patients
Mar 10, 2010 -- ZymoGenetics, Inc. (NASDAQ:ZGEN), today announced the presentation of safety and immunogenicity data among pediatric burn patients at the 42nd Annual Meeting of the American Burn Association in Boston, MA. The study marks the first dedicated look at the safety and immunogenicity of any stand-alone thrombin in pediatric surgical patients...
New Hope To Vitiligo Patients Offered By Skin Transplant
Mar 10, 2010 -- In the first study of its kind in the United States, Henry Ford Hospital showed that skin transplant surgery is safe and effective for treating vitiligo. Henry Ford researchers followed 23 patients for up to six months after surgery and found that the treated area regained on average 52 percent of its natural skin color...
FDA Approves Botox To Treat Spasticity In Flexor Muscles Of The Elbow, Wrist And Fingers
Mar 10, 2010 -- The U.S. Food and Drug Administration approved Botox (onabotulinumtoxin A) to treat spasticity in the flexor muscles of the elbow, wrist, and fingers in adults. Spasticity is common after stroke, traumatic brain injury, or the progression of multiple sclerosis...
Copyright 2007 Medical News Today
Login
Username:
Password:
Register
Forgot Password?
Ask the Expert
Have a question for one of our experts?
Submit it here

View all Questions

Participate in our
Online polls
How is bimatoprost ophthalmic solution (Latisse) integrated into treatment regimens in your practice?



Upcoming Events